These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 16299001)
1. Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. Allred KF; Smart EJ; Wilson ME J Biol Chem; 2006 Jan; 281(3):1419-25. PubMed ID: 16299001 [TBL] [Abstract][Full Text] [Related]
2. Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C. Bradshaw EL; Li XA; Guerin T; Everson WV; Wilson ME; Bruce-Keller AJ; Greenberg RN; Guo L; Ross SA; Smart EJ Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1271-8. PubMed ID: 16822947 [TBL] [Abstract][Full Text] [Related]
3. Estrogen prevents cholesteryl ester accumulation in macrophages induced by the HIV protease inhibitor ritonavir. Wilson ME; Sengoku T; Allred KF J Cell Biochem; 2008 Apr; 103(5):1598-606. PubMed ID: 17879945 [TBL] [Abstract][Full Text] [Related]
4. The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. Mencarelli A; Cipriani S; Renga B; Francisci D; Palladino G; Distrutti E; Baldelli F; Fiorucci S PLoS One; 2010 Oct; 5(10):e13238. PubMed ID: 20949026 [TBL] [Abstract][Full Text] [Related]
5. Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir. Guo W; Wong S; Pudney J; Jasuja R; Hua N; Jiang L; Miller A; Hruz PW; Hamilton JA; Bhasin S Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2028-32. PubMed ID: 19762785 [TBL] [Abstract][Full Text] [Related]
6. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. Dressman J; Kincer J; Matveev SV; Guo L; Greenberg RN; Guerin T; Meade D; Li XA; Zhu W; Uittenbogaard A; Wilson ME; Smart EJ J Clin Invest; 2003 Feb; 111(3):389-97. PubMed ID: 12569165 [TBL] [Abstract][Full Text] [Related]
7. Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice. Helsley RN; Sui Y; Ai N; Park SH; Welsh WJ; Zhou C Mol Pharmacol; 2013 Jun; 83(6):1190-9. PubMed ID: 23519392 [TBL] [Abstract][Full Text] [Related]
8. Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile. Arvieux C; Tribut O Drugs; 2005; 65(5):633-59. PubMed ID: 15748098 [TBL] [Abstract][Full Text] [Related]
9. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138 [TBL] [Abstract][Full Text] [Related]